Welcome to JOURNAL OF SICHUAN UNIVERSITY (MEDICAL SCIENCES) June 11, 2025
ZHENG Shi-ze, MENG Lin, REN Fei-long, et al. Oral Squamous Cell Carcinoma-Derived Cell-Free DNA Modulates Stemness and Migration of Oral Squamous Cell Carcinoma Cell Line by Inducing M2 Macrophage Polarization[J]. Journal of Sichuan University (Medical Sciences), 2023, 54(3): 510-516. DOI: 10.12182/20230560206
Citation: ZHENG Shi-ze, MENG Lin, REN Fei-long, et al. Oral Squamous Cell Carcinoma-Derived Cell-Free DNA Modulates Stemness and Migration of Oral Squamous Cell Carcinoma Cell Line by Inducing M2 Macrophage Polarization[J]. Journal of Sichuan University (Medical Sciences), 2023, 54(3): 510-516. DOI: 10.12182/20230560206

Oral Squamous Cell Carcinoma-Derived Cell-Free DNA Modulates Stemness and Migration of Oral Squamous Cell Carcinoma Cell Line by Inducing M2 Macrophage Polarization

More Information
  • Corresponding author:

    SUN Hong-chen, E-mail: hcsun@mail.jlu.edu.cn

  • Received Date: October 12, 2022
  • Revised Date: April 24, 2023
  • Available Online: May 19, 2023
  • Published Date: May 19, 2023
  •   Objective  To investigate the effect of oral squamous cell carcinoma (OSCC)-derived cell-free DNA (cfDNA) on the polarization of macrophages and the regulatory effect of polarized macrophages on the stemness and migration of OSCC cells.
      Methods  A total of 30 OSCC tissue samples, 10 dysplastic oral tissue samples, and 10 normal oral tissue samples were collected. The status of all tissue samples was confirmed by pathology analysis. Immunohistochemical (IHC) staining and immunofluorescence (IF) staining were performed to examine the cell count and location of M2 macrophages in different types of oral tissue samples. The conditioned medium (CM) of OSCC cell line CAL-27 from the human tongue was collected and the cfDNA was concentrated and isolated for identification. The macrophages were treated by cfDNA and their morphological characteristics were observed under microscope. The expression levels of polarization-related indicators were determined by RT-qPCR. CAL-27 cell line was treated with macrophage CM induced by cfDNA and the expression levels of stemness-related genes were determined by RT-qPCR. Scratch-wound assay was conducted to verify that the migration ability of CAL-27 was modulated by macrophages induced by cfDNA.
      Results  There were more M2 macrophages in the deep connective tissue of dysplastic oral epithelium and the stroma of OSCC compared with those in the normal oral tissues (P<0.05). OSCC cell line CAL-27 could secret cfDNA of 10000-15000 bp in length. cfDNA secreted by CAL-27 could induced in macrophages significantly higher expression of M2-macrophage-related genes (P<0.05). cfDNA-treated macrophages induced significantly increased expression of stemness-related genes in CAL-27 cell line (P<0.05) and promoted the migration ability of CAL-27 cell line (P<0.05).
      Conclusion  OSCC-derived cfDNA promotes stemness and migration of OSCC cell line by inducing M2 macrophage polarization.
  • [1]
    SUN L P, XU K, CUI J, et al. Cancerassociated fibroblastderived exosomal miR3825p promotes the migration and invasion of oral squamous cell carcinoma. Oncol Rep,2019,42(4): 1319–1328. DOI: 10.3892/or.2019.7255
    [2]
    IVALDI E, Di MARIO D, PADERNO A, et al. Postoperative radiotherapy (PORT) for early oral cavity cancer (pT1-2, N0-1): a review. Crit Rev Oncol Hematol,2019,143: 67–75. DOI: 10.1016/j.critrevonc.2019.08.003
    [3]
    LINDEMANN A, TAKAHASHI H, PATEL A A, et al. Targeting the DNA damage response in OSCC with TP53 mutations. J Dent Res,2018,97(6): 635–644. DOI: 10.1177/0022034518759068
    [4]
    DAN H, LIU S, LIU J, et al. RACK1 promotes cancer progression by increasing the M2/M1 macrophage ratio via the NF-kappaB pathway in oral squamous cell carcinoma. Mol Oncol,2020,14(4): 795–807. DOI: 10.1002/1878-0261.12644
    [5]
    FREITAS R D, DIAS R B, VIDAL M T A, et al. Inhibition of CAL27 oral squamous carcinoma cell by targeting hedgehog pathway with vismodegib or itraconazole. Front Oncol,2020,10: 563838. DOI: 10.3389/fonc.2020.563838
    [6]
    ZHANG Y Y, ZHANG Z M. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol,2020,17(8): 807–821. DOI: 10.1038/s41423-020-0488-6
    [7]
    ANDERSON N M, SIMON M C. The tumor microenvironment. Current Biol,2020,30(16): R921–R925. DOI: 10.1016/j.cub.2020.06.081
    [8]
    MANDEL P, METAIS P. Nuclear acids in human blood plasma. C R Seances Soc Biol Fil,1948,142(3/4): 241–243.
    [9]
    MITTRA I, KHARE N K, RAGHURAM G V, et al. Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. J Biosciences,2015,40(1): 91–111. DOI: 10.1007/s12038-015-9508-6
    [10]
    NIU Z C, TANG W T, LIU T Y, et al. Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer. Acta Bioch Bioph Sin,2018,50(10): 1007–1017. DOI: 10.1093/abbs/gmy104
    [11]
    KIRIKOVICH S S, TARANOV O S, OMIGOV V V, et al. Ultrastructural analysis of the Krebs-2 ascites cancer cells treated with extracellular double-stranded DNA preparation. Ultrastruct Pathol,2019,43(1): 56–65. DOI: 10.1080/01913123.2019.1575499
    [12]
    GOULD T J, LYSOV Z, LIAW P C. Extracellular DNA and histones: double-edged swords in immunothrombosis. J Thromb Haemost,2015,13: S82–S91. DOI: 10.1111/jth.12977
    [13]
    ANUNOBI R, BOONE B A, CHEH N, et al. Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy. J Surg Res,2018,226: 181–191. DOI: 10.1016/j.jss.2018.02.042
    [14]
    BRONKHORST A J, UNGERER V, HOLDENRIEDER S. Comparison of methods for the quantification of cell-free DNA isolated from cell culture supernatant. Tumour Biol,2019,41(8): 1010428319866369. DOI: 10.1177/1010428319866369
    [15]
    VANDEWOESTYNE M, Van HOOFSTAT D, FRANSSEN A, et al. Presence and potential of cell free DNA in different types of forensic samples. Forensic Sci Int Genet,2013,7(2): 316–320. DOI: 10.1016/j.fsigen.2012.12.005
    [16]
    MERKER J D, OXNARD G R, COMPTON C, et al. Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review. J Clin Oncol,2018,36: 1631–1641. DOI: 10.1200/JCO.2017.76.8671
    [17]
    WANG J , BETTEGOWDA C. Applications of DNA-based liquid biopsy for central nervous system neoplasms. J Mol Diagn,2017,19(1): 24–34. DOI: 10.1016/j.jmoldx.2016.08.007
    [18]
    HU Z, CHEN H, LONG Y, et al. The main sources of circulating cell-free DNA: apoptosis, necrosis and active secretion. Crit Rev Oncol Hematol,2021,157: 103166. DOI: 10.1016/j.critrevonc.2020.103166
    [19]
    STROUN M, LYAUTEY J, LEDERREY C, et al. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta,2001,313(1/2): 139–142. DOI: 10.1016/s0009-8981(01)00665-9
    [20]
    THAKUR B K, ZHANG H, BECKER A, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res,2014,24(6): 766–769. DOI: 10.1038/cr.2014.44
    [21]
    MOROZKIN E S, LAKTIONOV P P, RYKOVA E Y, et al. Release of nucleic acids by eukaryotic cells in tissue culture. Nucleosides Nucleotides Nucleic Acids,2004,23(6/7): 927–930. DOI: 10.1081/NCN-200026042
    [22]
    BRONKHORST A J, WENTZEL J F, AUCAMP J, et al. Characterization of the cell-free DNA released by cultured cancer cells. Biochim Biophys Acta,2016,1863(1): 157–165. DOI: 10.1016/j.bbamcr.2015.10.022
    [23]
    AUCAMP J, BRONKHORST A J, PETERS D L, et al. Kinetic analysis, size profiling, and bioenergetic association of DNA released by selected cell lines in vitro. Cell Mol Life Sci,2017,74(14): 2689–2707. DOI: 10.1007/s00018-017-2495-z
    [24]
    WALDVOGEL ABRAMOWSKI S, TIREFORT D, LAU P, et al. 24 are present in blood products and regulate genes of innate immune response. Transfusion,2018,58(7): 1671–1681. DOI: 10.1111/trf.14613
    [25]
    KORABECNA M, ZINKOVA A, BRYNYCHOVA I, et al. Cell-free DNA in plasma as an essential immune system regulator. Sci Rep,2020,10(1): 17478. DOI: 10.1038/s41598-020-74288-2
    [26]
    SMIRNOVA T, BONAPACE L, MACDONALD G, et al. Serpin E2 promotes breast cancer metastasis by remodeling the tumor matrix and polarizing tumor associated macrophages. Oncotarget,2016,7(50): 82289–82304. DOI: 10.18632/oncotarget.12927
    [27]
    YUNNA C, MENGRU H, LEI W, et al. Macrophage M1/M2 polarization. Eur J Pharmacol,2020,877: 173090. DOI: 10.1016/j.ejphar.2020.173090
    [28]
    KANG S, NAKANISHI Y, KIOI Y, et al. Semaphorin 6D reverse signaling controls macrophage lipid metabolism and anti-inflammatory polarization. Nat Immunol,2018,19(6): 561–570. DOI: 10.1038/s41590-018-0108-0
    [29]
    GUO M, HARTLOVA A, GIERLINSKI M, et al. Triggering MSR1 promotes JNK-mediated inflammation in IL-4-activated macrophages. EMBO J,2019,38: e100299. DOI: 10.15252/embj.2018100299
    [30]
    NAQVI I, GUNARATNE R, MCDADE J E, et al. Polymer-mediated inhibition of pro-invasive nucleic acid DAMPs and microvesicles limits pancreatic cancer metastasis. Mol Ther,2018,26(4): 1020–1031. DOI: 10.1016/j.ymthe.2018.02.018
    [31]
    LAUKOVA L, KONECNA B, JANOVICOVA L, et al. Deoxyribonucleases and their applications in biomedicine. Biomolecules,2020,10(7): 1036. DOI: 10.3390/biom10071036
  • Cited by

    Periodical cited type(1)

    1. 付勇青,徐三会,赵岩,王丽丽. SPP1、DEC1、C1QTNF6蛋白与口腔鳞状细胞癌患者临床病理指标及预后的关系. 癌变·畸变·突变. 2024(02): 107-111+117 .

    Other cited types(0)

Catalog

    Article views (1665) PDF downloads (44) Cited by(1)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return